BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32571644)

  • 1. Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap.
    Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Itoh K; Hashimoto S
    Allergol Int; 2021 Jan; 70(1):136-139. PubMed ID: 32571644
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
    Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
    Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
    Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
    James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
    Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.
    Tang H; Fang Z; Sun Y; Li B; Shi Z; Chen J; Zhang T; Xiu Q
    Eur Respir J; 2010 Apr; 35(4):757-60. PubMed ID: 20356987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.
    George L; Taylor AR; Esteve-Codina A; Soler Artigas M; Thun GA; Bates S; Pavlidis S; Wagers S; Boland A; Prasse A; Boschetto P; Parr DG; Nowinski A; Barta I; Hohlfeld J; Greulich T; van den Berge M; Hiemstra PS; Timens W; Hinks T; Wenzel S; Siddiqui S; Richardson M; Venge P; Heath S; Gut I; Tobin MD; Edwards L; Riley JH; Djukanovic R; Auffray C; De-Meulder B; Erik-Dahlen S; Adcock IM; Chung KF; Ziegler-Heitbrock L; Sterk PJ; Singh D; Brightling CE;
    Allergy; 2020 Feb; 75(2):370-380. PubMed ID: 31506971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.
    Katoh S; Ikeda M; Shirai R; Abe M; Ohue Y; Kobashi Y; Oka M
    J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of serum YKL-40 levels for identification of patients with asthma and COPD.
    Gon Y; Maruoka S; Ito R; Mizumura K; Kozu Y; Hiranuma H; Hattori T; Takahashi M; Hikichi M; Hashimoto S
    Allergol Int; 2017 Oct; 66(4):624-626. PubMed ID: 28285848
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
    Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
    J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.
    Peng J; Wang M; Wu Y; Shen Y; Chen L
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2567-2575. PubMed ID: 36259043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
    Otsuka K; Matsumoto H; Niimi A; Muro S; Ito I; Takeda T; Terada K; Yamaguchi M; Matsuoka H; Jinnai M; Oguma T; Nakaji H; Inoue H; Tajiri T; Iwata T; Chin K; Mishima M
    Respiration; 2012; 83(6):507-19. PubMed ID: 21968467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD.
    Mochimaru T; Chubachi S; Irie H; Sakurai K; Okuzumi S; Sunata K; Masaki K; Miyata J; Nakamura H; Asano K; Fukunaga K
    Allergol Int; 2021 Apr; 70(2):255-257. PubMed ID: 33087300
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of Asthma/COPD Overlap in FDNY Firefighters With World Trade Center Dust Exposure: A Longitudinal Study.
    Singh A; Liu C; Putman B; Zeig-Owens R; Hall CB; Schwartz T; Webber MP; Cohen HW; Berger KI; Nolan A; Prezant DJ; Weiden MD
    Chest; 2018 Dec; 154(6):1301-1310. PubMed ID: 30028968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchial asthma--significant obstruction is also found in clinically stable asthma ].
    Appel K
    Pneumologie; 2007 Oct; 61(10):626. PubMed ID: 17922384
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of Exhaled Nitric Oxide (FeNO) And Eosinophilia During the Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Hospital Admission.
    Río Ramírez MT; Juretschke Moragues MA; Fernández González R; Álvarez Rodríguez V; Aznar Andrés E; Zabaleta Camino JP; Romero Pareja R; Esteban de la Torre A
    COPD; 2018; 15(4):369-376. PubMed ID: 30064275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.
    Kolsum U; Ravi A; Hitchen P; Maddi S; Southworth T; Singh D
    Respir Res; 2017 Apr; 18(1):73. PubMed ID: 28446172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.